Kelland LR - Search Results

1

In vitro prevention of the emergence of multidrug resistance in a pediatric rhabdomyosarcoma cell line.

Cocker HA, Tiffin N, Pritchard-Jones K, Pinkerton CR, Kelland LR. Cocker HA, et al. Among authors: kelland lr. Clin Cancer Res. 2001 Oct;7(10):3193-8. Clin Cancer Res. 2001. PMID: 11595714

2

Characterization and modulation of drug resistance of human paediatric rhabdomyosarcoma cell lines.

Cocker HA, Pinkerton CR, Kelland LR. Cocker HA, et al. Among authors: kelland lr. Br J Cancer. 2000 Aug;83(3):338-45. doi: 10.1054/bjoc.2000.1273. Br J Cancer. 2000. PMID: 10917549 Free PMC article.

3

High levels of the MDM2 oncogene in paediatric rhabdomyosarcoma cell lines may confer multidrug resistance.

Cocker HA, Hobbs SM, Tiffin N, Pritchard-Jones K, Pinkerton CR, Kelland LR. Cocker HA, et al. Among authors: kelland lr. Br J Cancer. 2001 Nov 30;85(11):1746-52. doi: 10.1054/bjoc.2001.2145. Br J Cancer. 2001. PMID: 11742497 Free PMC article.

4

Establishment and characterization of acquired resistance to the farnesyl protein transferase inhibitor R115777 in a human colon cancer cell line.

Smith V, Rowlands MG, Barrie E, Workman P, Kelland LR. Smith V, et al. Among authors: kelland lr. Clin Cancer Res. 2002 Jun;8(6):2002-9. Clin Cancer Res. 2002. PMID: 12060646

5

Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.

Sharp SY, Rogers PM, Kelland LR. Sharp SY, et al. Among authors: kelland lr. Clin Cancer Res. 1995 Sep;1(9):981-9. Clin Cancer Res. 1995. PMID: 9816070

6

Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line.

Kelland LR, Mistry P, Abel G, Freidlos F, Loh SY, Roberts JJ, Harrap KR. Kelland LR, et al. Cancer Res. 1992 Apr 1;52(7):1710-6. Cancer Res. 1992. PMID: 1312897

7

Lack of a role for MRP1 in platinum drug resistance in human ovarian cancer cell lines.

Sharp SY, Smith V, Hobbs S, Kelland LR. Sharp SY, et al. Among authors: kelland lr. Br J Cancer. 1998 Jul;78(2):175-80. doi: 10.1038/bjc.1998.461. Br J Cancer. 1998. PMID: 9683290 Free PMC article.

8

A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.

Kelland LR, Barnard CF, Mellish KJ, Jones M, Goddard PM, Valenti M, Bryant A, Murrer BA, Harrap KR. Kelland LR, et al. Cancer Res. 1994 Nov 1;54(21):5618-22. Cancer Res. 1994. PMID: 7923207

9

ras mutation and platinum resistance in human ovarian carcinomas in vitro.

Holford J, Rogers P, Kelland LR. Holford J, et al. Among authors: kelland lr. Int J Cancer. 1998 Jul 3;77(1):94-100. doi: 10.1002/(sici)1097-0215(19980703)77:1<94::aid-ijc15>3.0.co;2-9. Int J Cancer. 1998. PMID: 9639399

10

Preclinical antitumor activity and pharmacodynamic studies with the farnesyl protein transferase inhibitor R115777 in human breast cancer.

Kelland LR, Smith V, Valenti M, Patterson L, Clarke PA, Detre S, End D, Howes AJ, Dowsett M, Workman P, Johnston SR. Kelland LR, et al. Clin Cancer Res. 2001 Nov;7(11):3544-50. Clin Cancer Res. 2001. PMID: 11705875

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters